All research involving recombinant or synthetic nucleic acid molecules, biohazardous agents (e.g. bacteria, viruses, fungi, protozoa, prions) and/or human and non-human primates source materials (e.g. blood, bodily secretions and tissues, primary and established cell lines), must be registered with the IBC.
To be registered with the IBC, Principal Investigators (PIs) must submit a protocol describing procedures and practices to safely conduct projects involving items within the IBC purview.
IBC protocols for basic research can be submitted through an electronic application while clinical studies have a distinct process of registration.
IBC Overview and Related Materials
IBC Database (Quick Access)
Human Clinical Research
IBC Required Training
Depending on the items listed on IBC protocols, authorized personnel might need to complete/update training, before protocols are approved. Click HERE for the list of IBC required training.
Lab Inspections & Lab Departure
As part of the post-approval monitoring program, BSL2 laboratories are inspected at least annually. For the of this procedure and related documents, please go HERE.
Leaving UC or relocating? Click HERE for more information.
Shipment of Biohazardous Material and/or Dry Ice
Individuals packing materials for shipment, must complete required training – Go HERE.
DURC - Dual Use Research of Concern
Few life sciences research may present a high potential for yielding knowledge, products, or technology that could be directly misapplied to threaten public health or national security. Research involving certain organisms must be reviewed by the Institutional Review Entity. Click HERE for more information.